AKT1 and cancer: One such example is the PI3K/Akt/mTOR pathway (31), whose dysregulation has been linked to a wide range of cancer symptoms, including abnormal cell growth, genetic mutations, and metabolic reprogramming in cancerous cells; activation of this system is one of the main causes of cancer cell resistance to anticancer therapies (32).